Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,087 across all filing types
Latest filing 2023-06-13 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Network International Holdings Plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details shareholdings, derivative positions, and recent dealings. This type of disclosure is a specific regulatory requirement and falls under the category of Major Shareholding Notification (MRQ) as it pertains to significant ownership and dealing disclosures in the context of a takeover.
2023-06-13 English
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details positions and dealings in the securities of 'NETWORK INTERNATIONAL HOLDINGS PLC'. Since this is a specific regulatory disclosure form and not a general announcement or a report, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate classification for this type of mandatory market surveillance disclosure.
2023-06-12 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel rules. It details the interests, short positions, and dealings in the securities of 'Horizon Therapeutics PLC' by 'Citadel Group'. This type of filing is a standard regulatory disclosure regarding major shareholding and derivative positions in the context of a takeover or merger, which falls under the 'Major Shareholding Notification' category.
2023-06-12 English
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details the 'Opening Position Disclosure' and 'Dealing Disclosure' by Citadel Group regarding their interests in Horizon Therapeutics PLC. This type of filing is specifically used to report significant shareholding positions and dealings during a takeover or merger process. While it relates to M&A activity, it is a specific regulatory disclosure form rather than a general M&A announcement (TAR). Therefore, it is best classified as a Regulatory Filing (RNS) as it is a mandatory disclosure submitted to a Regulatory Information Service.
2023-06-09 English
Form 8.3 - Network International Holdings Plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details positions and dealings in the securities of 'NETWORK INTERNATIONAL HOLDINGS PLC'. Since this is a specific regulatory disclosure form related to takeover activity and shareholding thresholds, it falls under the 'Major Shareholding Notification' category.
2023-06-09 English
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 97% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in relation to an offeror or offeree during a takeover period. This specific type of disclosure is a regulatory requirement for major shareholders or entities involved in M&A activity to report their holdings and transactions. Since it is a specific regulatory disclosure regarding shareholdings and dealings during a takeover, it falls under the 'Major Shareholding Notification' category.
2023-06-08 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.